scispace - formally typeset
Search or ask a question

Showing papers on "Protein–protein interaction published in 1994"


Journal ArticleDOI
TL;DR: This method, termed USPS (ubiquitin-based split-protein sensor), makes it possible to monitor a protein-protein interaction as a function of time, at the natural sites of this interaction in a living cell.
Abstract: We describe an assay for in vivo protein interactions. Protein fusions containing ubiquitin, a 76-residue, single-domain protein, are rapidly cleaved in vivo by ubiquitin-specific proteases, which recognize the folded conformation of ubiquitin. When a C-terminal fragment of ubiquitin (C(ub)) is expressed as a fusion to a reporter protein, the fusion is cleaved only if an N-terminal fragment of ubiquitin (Nub) is also expressed in the same cell. This reconstitution of native ubiquitin from its fragments, detectable by the in vivo cleavage assay, is not observed with a mutationally altered Nub. However, if C(ub) and the altered Nub are each linked to polypeptides that interact in vivo, the cleavage of the fusion containing C(ub) is restored, yielding a generally applicable assay for kinetic and equilibrium aspects of in vivo protein interactions. This method, termed USPS (ubiquitin-based split-protein sensor), makes it possible to monitor a protein-protein interaction as a function of time, at the natural sites of this interaction in a living cell.

800 citations


Journal ArticleDOI
TL;DR: The two-hybrid system is a yeast-based genetic assay for detecting protein-protein interactions that has been developed to clone genes that encode DNA-binding proteins, to identify peptides that bind to a protein and, potentially, to screen for drugs.

740 citations


Journal ArticleDOI
01 Oct 1994-Virology
TL;DR: Analysis of transient transfections of serially extended templates covering the E2/NS2 region provided evidence for three E2 species with distinct C-termini, indicating that complex processing and protein:protein interactions occur during HCV morphogenesis.

150 citations


Journal ArticleDOI
TL;DR: It was found that the 51 kDa protein is indeed FA‐1 antigen, and these antigens will find application in the development of a multivalent contraceptive vaccine, and may also help in specific diagnosis and treatment of infertility mediated through defective gamete (sperm or oocyte) function.
Abstract: The present study was conducted to investigate the molecular identities, nature of interaction, and tyrosine phosphorylation activity of the spermzona pellucida binding proteins in humans. Sperm proteins belcnging to four major molecular regions, namely 95, 63, 51, and 14–18 kDa, reacted with zona pellucida proteins in the Western blot and immunoprecipitation procedures. In these procedures, zona pellucida protein that reacted strongest with the sperm proteins belonged to the molecular region of 55 kDa (ZP3), besides weakly reacting proteins in the 110-kDa (ZP1/ZP2) and 14–18-kDa molecular regions. The major forces involved in the sperm-zona protein interactions were of hydrophobic and ionic in nature. Three (95, 51, and 14–18 kDa) of the four molecular regions of sperm proteins that bound to the zona pellucida proteins also seem to involve o-phospho-L-tyrosine residues in their interaction, and these proteins demonstrated the presence of phosphotyrosine residues, and the 51-kDa protein also showed autophosphorylating activity in the in vitro kinase assay. The sperm binding zona protein of 55 kDa also demonstrated autophosphorylating activity. Using specific monoclonal antibody to the well characterized sperm-specific glycoprotein, designated FA-1, and the competitive inhibition in the immunoprecipitation procedure, it was found that the 51 kDa protein is indeed FA-1 antigen. Besides elucidating the molecular nature of the spermzona interaction, these antigens will find application in the development of a multivalent contraceptive vaccine, and may also help in specific diagnosis and treatment of infertility mediated through defective gamete (sperm or oocyte) function. © 1994 Wiley-Liss, Inc.

69 citations




Journal ArticleDOI
TL;DR: The unexpected effects of some amino-acid substitutions indicate that the interactions seen between SH2 domains and ligand in the crystal structure may not be identical to those that occur in solution.

37 citations


Journal ArticleDOI
TL;DR: Observations indicate that the specific protein-protein interactions that occur between the three prespliceosomal factors have been conserved between yeast and mammals.
Abstract: Spliceosome-associated proteins (SAPs) 61, 62, and 114 can be UV-crosslinked to pre-mRNA in purified spliceosomal complexes and are associated with U2 small nuclear ribonucleoproteins (snRNP). These proteins also compose the essential heterotrimeric splicing factor SF3a, and products of yeast pre-mRNA processing genes PRP9, PRP11, and PRP21 are their likely yeast counterparts. We report the isolation of a cDNA encoding SAP 61 and find that it is 30% identical in amino acid sequence to PRP9. A C-terminal Cys2His2 zinc-finger-like motif, which could be involved in the pre-mRNA binding, is the most highly conserved region of the protein. We also demonstrate specific protein-protein interactions between SAPs 61 and 114 and show that the N terminus of SAP 61 is required for this interaction. Significantly, the corresponding proteins are also known to interact in yeast: PRP9 interacts with PRP21, and the N-terminal portion of PRP9 is required. Previous work showed that direct interactions also occur between SAPs 62 and 114 and between the corresponding PRPs 11 and 21. These observations indicate that the specific protein-protein interactions that occur between the three prespliceosomal factors have been conserved between yeast and mammals.

35 citations


Journal ArticleDOI
Robert F. Kelley1
01 Jun 1994-Methods
TL;DR: Results with two systems, a humanized antibody binding to antigen and coagulation factor VII binding to the cofactor protein tissue factor, are used to describe the use of biosensor technology in mapping protein-protein interfaces and show that the BlAcore instrument is a powerful tool for evaluating protein- protein interactions.

21 citations


Patent
12 Sep 1994
TL;DR: In this paper, the authors proposed a method for detecting dimer formation (ligand dependent or ligand independent) of a fusion protein, which can be used to generate a signal from a variety of ligand-binding domains, allowing ligand binding to be indicated by a simple colorimeteric test or antibiotic resistance.
Abstract: The present invention relates to: (1) a fusion protein having a dimerizing domain with or without a ligand-binding region and tox R DNA-binding and hydrophobic transmembrane regions; (2) host cells comprising the fusion protein and a nucleic acid molecule having a reporter gene operatively linked to the ctx operon, wherein dimerization (ligand-dependent or -independent) is signaled by expression of the reporter gene; (3) a nucleic acid molecule coding for the fusion protein; (4) an expression vector comprising a coding region for the fusion protein; (5) a process for detecting dimer formation (ligand dependent or ligand independent) of the fusion protein, which comprises treating a culture of the host cells with a ligand, ligand mimetic, or dimerization inhibitor, and screening for expression of the reporter gene. The present invention can be used to generate a signal from a variety of ligand-binding domains, allowing ligand binding to be indicated by a simple colorimeteric test or antibiotic resistance. The fusion proteins could include therapeutically relevant domains, so that biologically pertinent interactions can be indicated by a readily measurable signal.

15 citations


Patent
16 Jun 1994
TL;DR: In this paper, a method for detecting ligand/receptor interactions was proposed, as well as the regents useful in the method, including DNA and host cells, and vaccines and kits comprising the expression products and the host cells of the invention.
Abstract: Provided by the present invention are novel methods of detecting ligand interactions, as well as regents useful in the method, including DNA and host cells; and more specifically relates to novel methods for the detection of protein/protein interactions and their application in epitope mapping and the study of ligand/receptor interactions. Also provided are vaccines and kits comprising the expression products and host cells of the invention.

Journal Article
TL;DR: Three particular targets in the growth factor signalling pathways are highlighted: growth factor - receptor binding, using Gastrin Releasing Peptide as a specific example; SH2 I SH3 domain interactions; and viral oncoprotein interaction with cellular proteins in the nucleus, focusing on the binding of Human Papillomavirus proteins with cellular growth suppressor gene products.
Abstract: The recent elucidation of many of the pathways involved in the regulation of cellular proliferation provides new opportunities for therapeutic intervention in the treatment of cancer. The inherent specificity of many of these protein-protein interactions should provide great selectivity, and emerging models of cell cycle control suggest that disrupting growth factor signalling pathways might selective_ly induce programmed cell death in cancer cells. However, many of these protein-protein interactions appear to occur over fairly large surfaces, suggesting that the identification of small molecules with the necessary affinity and specificity to disrupt these interactions in vivo represents a challenging undertaking. In the current review, we highlight three particular targets in the growth factor signalling pathways : growth factor - receptor binding, using Gastrin Releasing Peptide as a specific example; SH2 I SH3 domain interactions; and viral oncoprotein interaction with cellular proteins in the nucleus, focusing on the binding of Human Papillomavirus proteins with cellular growth suppressor gene products. These studies highlight both the promise and the pitfalls of selectively targeting protein-protein interactions for the treatment of cancer.

Book ChapterDOI
TL;DR: This chapter describes the thermodynamic linkage between denaturant binding to proteins and the effect on thermal stability with an emphasis on the developments and applications utilizing GuHCl as a chemical destabilizing agent of protein structure.
Abstract: Publisher Summary Elucidation of the detailed energetics of protein folding-unfolding equilibria together with knowledge of specific structural information provides a powerful means for gaining a productive understanding of (1) the principles involved in regulating protein folding, (2) domain interactions within proteins, (3) multimolecular protein interactions and assembly into higher order macromolecular structures, (4) interactions of proteins with biological membranes, and (5) functional associations between proteins and small ligands. Direct access to protein energetics is possible by application of calorimetric techniques and, in particular, differential scanning calorimetry (DSC). DSC permits direct measurement of the enthalpy and heat capacity changes associated with thermally induced protein denaturation. Complex protein energetics can be elucidated by application of two-dimensional DSC methods in conjunction with the chemical protein structural destabilizing agent guanidinium hydrochloride (GuHCl). This chapter describes the thermodynamic linkage between denaturant binding to proteins and the effect on thermal stability with an emphasis on the developments and applications utilizing GuHCl as a chemical destabilizing agent of protein structure.

Journal ArticleDOI
TL;DR: Fusion proteins containing noncatalytic elements of two highly related SRC‐family members were tested for their ability to recognize distinct molecules present in lysates of cells known to normally express both enzymes.

Journal ArticleDOI
TL;DR: The correlation between transcriptional activity and the formation of these complexes suggests that the observed protein--DNA interactions are important for transcription of 5S RNA genes.
Abstract: Specific protein-DNA complexes formed on a Xenopus 5S RNA gene were isolated and characterized using a novel technique. A DNA template reversibly immobilized on paramagnetic beads was used to capture, affinity purify, and concentrate protein--DNA complexes formed in a whole cell extract. The complexes were then released from the beads in a soluble and transcriptionally active form via restriction enzyme digestion of the DNA. A band-shift gel was used to separate and obtain the DNase I footprints of five individual complexes. Three of the complexes resulted from the independent binding of two proteins, TFIIIA and an unidentified protein binding to a large region just downstream of the 3' end of the gene. Two more slowly migrating complexes contained an additional large central protected region covering most of the gene. The most slowly migrating complex displayed protein interactions over the 5' flanking sequences. The formation of two of these complexes was shown to be dependent on TFIIIC activity. The correlation between transcriptional activity and the formation of these complexes suggests that the observed protein--DNA interactions are important for transcription of 5S RNA genes.

Journal Article
01 Mar 1994-Oncogene
TL;DR: The results suggest a novel mechanism to alter the equilibrium between different transactivating protein complexes of the b-HLH class, which can dramatically shift upon subtle mutations in the loop region and the second helix of the E47 protein.
Abstract: Several mutants of the E47 protein, a member of the family of basic/helix-loop-helix (b-HLH) transcriptional regulators, were examined for their ability to homo- and heterodimerize with the protein product of the T-cell oncogene tal-1/SCL. For this purpose, a novel bacterial expression system was developed in which proteins are expressed as fusions appended to glutathione-S-transferase via a thrombin cleavage site and either one or four protein kinase recognition sites embedded in a glycine-rich domain. Since the interaction domain can be purified away from the glutathione-S-transferase moiety and the radioactive label is located in a flexible N-terminal tag, protein folding should occur normally. Our studies with E47 proteins prepared in this system indicate that the ratio between E47 homodimers and E47/tal-1 heterodimers can dramatically shift upon subtle mutations in the loop region and the second helix of the E47 protein. This unexpected results suggests a novel mechanism to alter the equilibrium between different transactivating protein complexes of the b-HLH class.


Book ChapterDOI
01 Jan 1994
TL;DR: The blot overlay assay is a powerful method used to study the specificity of protein–protein interactions and provides an especially useful means that helps in identifying potential protein ligands.
Abstract: Publisher Summary This chapter focuses on the blot overlay assay method to detect protein–protein interactions. The blot overlay assay is a powerful method used to study the specificity of protein–protein interactions and provides an especially useful means that helps in identifying potential protein ligands. In this approach, a radiolabeled protein probe is used to overlay protein samples immobilized on nitrocellulose. Because this assay allows detection of protein–protein interactions within the context of a complex mixture of proteins, this method is also useful to investigate the specificity of an interaction between two ligands. For example, proteolytic fragments of proteins or nested deletion fragments may be probed to determine the portion of a molecule that contains the interactive site. However, the blot overlay assay is not a native assay and the interactions detected by this approach should be confirmed by employing solution binding assays under native conditions.


Dissertation
01 Jan 1994
TL;DR: It was shown that a region of 90 amino acids at the N-terminus of the b2-3 protein is sufficient for dimerisation with b1-1, suggesting that a compatible A mating type reaction and thus allele specificity is recognised by the ability to dimerise through this domain.
Abstract: The A mating type factor of the hymenomycete fungus Coprinus cinereus is a multi-allelic gene complex that controls mating compatibility and sexual development. It contains up to four pairs of specificity genes, the a , b , c , and d gene-pairs. Each gene-pair codes for two homeodomain transcription factors with distinct classes of homeodomain motifs. Mating compatibility between the A 42 and A 6 factors depends solely on the different alleles of the b gene-pair, b1-1 and b2-1 in A 42 and b1-3 and b2-3 in A 6. The b1-3 and b2-3 genes of A 6 were isolated and the complete DNA sequences of genomic and cDNA clones were determined. Construction of chimeric genes using the A 42 and A 6 b genes identified the N-terminal regions of the A proteins as being responsible for allele specificity. Analysis of protein-protein interactions showed that b1 and b2 proteins from different alleles of the same gene-pair can dimerise, whereas proteins from the same allele pair can not. It was shown that a region of 90 amino acids at the N-terminus of the b2-3 protein is sufficient for dimerisation with b1-1. This region is predicted to contain an amphipathic helix. A comparison with the equivalent region in the b2-1 protein identifies a similar helix. This suggests that a compatible A mating type reaction and thus allele specificity is recognised by the ability to dimerise through this domain. Polyclonal antibodies were raised against the b1-1 protein and a heterologous yeast expression system was established for testing potential DNA target sites of the b1-1 and b2-3 proteins, both techniques offering potentially useful tools for further molecular analysis of the A mating type proteins.

01 Jan 1994
TL;DR: Mutational analyses have provided an insight into how the interplay of many regulatory factors occurs on the surface of a target factor, TBP, to specify and regulate transcriptional activity, and showed that the proline-rich activation domain of CTFl can activate transcription in yeast and human.
Abstract: Various in VlVO and in vitro assays have been employed to analyze how activators communicate with the general transcription machinery to stimulate transcription. As a first step, I analyzed the function of distinct kinds of activation domains in yeast and human. The results showed that the proline-rich activation domain of CTFl can, like acidic activation domains, activate transcription in yeast and human. Based on this, I compared the activation pathways by acidic and proline-rich activation domains in yeast and human. These detailed comparative approaches yielded clues to the fundamental aspects of transcriptional activation mechanism in eukaryotes: activators target TF11D(TBP)-TF11B­ promoter complex formation in the preinitiation complex assembly process by inducing (or stabilizing) qualitative or quantitative alterations within TF11D(TBP)-TF11B-promoter complexes that consequently enhance recruitment of downstream initiation factors. Consistent with this view, various activation domains have been demonstrated to have physical and functional interactions with TBP and/or TF11B. Given the central role of TBP in transcriptional regulation, I also identified distinct TBP domains (or residues) important for different regulatory interactions including those with acidic activators, TF11B, Drl (NC2) , Pol 1and Pol 111specific factors. These mutational analyses have provided an insight into how the interplay of many regulatory factors occurs on the surface of a target factor, TBP, to specify and regulate transcriptional activity. Furthermore, I investigated the